PARP inhibitor - PDFSEARCH.IO - Document Search Engine

PARP inhibitor
Results: 49

#	Item
11	“An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer.” Newsletter2014 Advances in Basic Research There was a tremendous amount of new development Add to Reading List Source URL: www.sabcs.org Language: English - Date: 2014-12-17 14:40:00 Ribbon symbolism Trastuzumab Ovarian cancer Cancer Targeted therapy PARP inhibitor PALB2 Bevacizumab Triple-negative breast cancer Medicine Oncology Breast cancer
12	9th conf_web banner_revised2 Add to Reading List Source URL: www.ootr.org Language: English - Date: 2013-03-27 03:10:54 Organofluorides Amines Quinazolines Ribbon symbolism PARP inhibitor Olaparib Targeted therapy PARP1 Triple-negative breast cancer Medicine Chemistry Angiology
13	Citation: Cell Death and Disease[removed], e1076; doi:[removed]cddis[removed] & 2014 Macmillan Publishers Limited All rights reserved[removed]www.nature.com/cddis Expression of base excision repair key factors and Add to Reading List Source URL: www.nature.com Language: English - Date: 2014-02-20 10:01:36 DNA repair Tumor markers Tumor suppressor genes Breast cancer Mutation PARP1 PARP inhibitor BRCA1 Base excision repair Biology Medicine Oncology
14	This is the author’s version of a work that was submitted/accepted for publication in the following source: Jekimovs, Christian, Bolderson, Emma, Suraweera, Amila, Adams, Mark, O’Byrne, Kenneth J., & Richard, Derek J Add to Reading List Source URL: eprints.qut.edu.au Language: English - Date: 2014-10-07 04:35:37 DNA repair Programmed cell death Cell cycle PARP inhibitor P53 RAD51 Ataxia telangiectasia mutated Homologous recombination BRCA1 Biology Tumor suppressor genes Proteins
15	March[removed]Making a difference with chemistry You may enjoy studying chemistry, but how can you use it to make a difference Add to Reading List Source URL: www.hoddereducation.co.uk Language: English - Date: 2015-03-05 09:09:56 PARP inhibitor Autoimmune diseases Olaparib Poly ADP ribose polymerase Ankylosing spondylitis TNF inhibitor Targeted therapy Non-steroidal anti-inflammatory drug Disease-modifying antirheumatic drug Medicine Biology Pharmacology
16	MSAC Application 1380 Germline BRCA mutation testing to determine eligibility for olaparib maintenance therapy in women with platinum-sensitive relapsed ovarian cancer (including fallopian tube or primary peritoneal canc Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-12-15 23:44:33 Primary peritoneal carcinoma Olaparib Ovarian cancer BRCA mutation Fallopian tube cancer PARP1 Serous carcinoma PARP inhibitor Breast cancer Medicine Oncology Gynaecological cancer
17	MSAC Application 1380 Germline BRCA mutation testing to determine eligibility for olaparib maintenance therapy in women with platinum-sensitive relapsed ovarian cancer (including fallopian tube or primary peritoneal canc Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-12-15 23:44:34 Olaparib Primary peritoneal carcinoma Ovarian cancer BRCA mutation Fallopian tube cancer PARP1 Serous carcinoma PARP inhibitor Breast cancer Medicine Oncology Gynaecological cancer
18	Poly(ADP-Ribose) Polymerase 1 Participates in the Phase Entrainment of Circadian Clocks to Feeding Gad Asher,1,* Hans Reinke,2,5 Matthias Altmeyer,3,4,5 Maria Gutierrez-Arcelus,1 Michael O. Hottiger,3 and Ueli Schibler1, Add to Reading List Source URL: www.molbio.unige.ch Language: English - Date: 2011-06-08 05:03:16 DNA repair Poly ADP ribose polymerase Programmed cell death PARP1 Nucleotides PARP inhibitor PER2 ARNTL CLOCK Biology Transcription factors Circadian rhythms
19	Turning Point From the Susan F. Smith Center for Women’s Cancers at Dana-Farber Cancer Institute A Vision for Success Bridging research and clinical care in women’s cancers Add to Reading List Source URL: www.dana-farber.org Language: English - Date: 2011-07-14 16:37:07 Cancer organizations Ribbon symbolism Ovarian cancer Cancer Triple-negative breast cancer Dana–Farber Cancer Institute PARP inhibitor BRCA1 BRCA mutation Medicine Oncology Breast cancer
20	Published OnlineFirst August 22, 2012; DOI:[removed].CD[removed]PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition Yasir H. Ibrahim, Celina Add to Reading List Source URL: openwetware.org Language: English - Date: 2012-11-13 10:21:44 Tumor suppressor genes Tumor markers Breast cancer Lactams PARP inhibitor Ribbon symbolism Olaparib Phosphoinositide 3-kinase Poly ADP ribose polymerase Medicine Oncology Biology

UPDATE